Current Developments in GLP-1 Agonists and Obesity Treatment | Retatrutide News
Eli Lilly is focusing on GLP-1 agonists like Retatrutide for obesity treatment. The role of AI in drug development is also highlighted.
Market News · October 9, 2026
Eli Lilly is focusing on GLP-1 agonists like Retatrutide for obesity treatment. The role of AI in drug development is also highlighted.
Market News · October 9, 2026